Understanding the HIDA Scan with CCK Stimulation (Sincalide)

A Hepatobiliary Iminodiacetic Acid (HIDA) scan, also known as cholescintigraphy, is a sophisticated nuclear medicine imaging procedure used to evaluate the health and function of the gallbladder and the biliary tree. When a HIDA scan is performed with CCK (Sincalide) stimulation, it becomes a dynamic functional study capable of calculating the Gallbladder Ejection Fraction (GBEF). This guide provides a comprehensive overview for patients, clinicians, and medical professionals regarding the technical, clinical, and procedural aspects of this diagnostic tool.

Technical Specifications and Mechanism of Action

The HIDA scan relies on the physiological processing of radiopharmaceuticals by the liver. The most commonly used tracer is Technetium-99m labeled iminodiacetic acid (e.g., Tc-99m mebrofenin or disofenin).

The Radiopharmaceutical Pathway

1. Injection: The tracer is injected intravenously.
2. Hepatic Uptake: The liver cells (hepatocytes) extract the tracer from the blood, similar to how they process bilirubin.
3. Excretion: The tracer is excreted into the bile canaliculi and flows through the biliary ducts into the gallbladder and the duodenum.
4. Imaging: A gamma camera captures the movement of the tracer over time.

The Role of Sincalide (CCK)

Cholecystokinin (CCK) is a natural hormone released by the duodenum in response to dietary fat. Sincalide is the synthetic, C-terminal octapeptide analog of CCK.

In this procedure, Sincalide is infused intravenously after the gallbladder has been visualized. It acts as a pharmacological stimulus, causing the gallbladder to contract. By measuring the amount of tracer that leaves the gallbladder during this contraction, physicians calculate the Gallbladder Ejection Fraction (GBEF).

Clinical Indications and Usage

A HIDA scan with CCK is primarily indicated when patients present with symptoms of biliary colic (RUQ pain, nausea, post-prandial discomfort) but have had inconclusive or normal results on an ultrasound.

Primary Clinical Indications

• Chronic Acalculous Cholecystitis: Inflammation of the gallbladder in the absence of gallstones.
• Biliary Dyskinesia: A functional disorder where the gallbladder fails to contract properly.
• Sphincter of Oddi Dysfunction: Assessment of bile flow obstruction at the ampulla of Vater.
• Post-surgical Evaluation: Assessing biliary patency after gallbladder or liver surgery.
• Bile Leakage: Detecting leaks following cholecystectomy or liver transplantation.

When is it contraindicated?

• Pregnancy: Nuclear medicine studies are generally avoided unless the diagnostic benefit significantly outweighs the radiation risk.
• Breastfeeding: Requires a temporary cessation of breastfeeding (usually 12–24 hours, depending on the tracer used).
• High Bilirubin Levels: If serum bilirubin is significantly elevated, the tracer may not be adequately excreted by the liver, leading to poor image quality.

Patient Preparation and Procedure Steps

Proper preparation is vital to ensure the accuracy of the GBEF calculation and avoid false-positive results.

Pre-Procedure Instructions

• Fasting: Patients must typically fast for at least 4 to 6 hours before the scan. Fasting ensures the gallbladder is full of bile and ready to respond to the CCK stimulus.
• Medication Review: Opioids and certain anticholinergics can interfere with biliary dynamics and should be withheld for 24 hours prior if possible, under physician guidance.

Step-by-Step Procedure

1. IV Access: An IV line is established for the administration of the radiopharmaceutical and Sincalide.
2. Initial Imaging: The tracer is injected, and dynamic imaging is performed for 60–90 minutes to observe gallbladder filling.
3. Sincalide Infusion: If the gallbladder fills, Sincalide is infused slowly (usually over 30–60 minutes) to prevent gallbladder spasm.
4. Ejection Phase: Imaging continues during the infusion to measure the contraction.
5. Data Processing: The technologist draws "Regions of Interest" (ROI) around the gallbladder to calculate the percentage of tracer ejected.

Risks and Radiation Exposure

The HIDA scan is considered a low-risk procedure. The primary concern is radiation exposure, which is comparable to or less than that of a standard CT scan.

The radiation risk is outweighed by the clinical necessity of diagnosing biliary dysfunction, which, if left untreated, could lead to more severe complications like cholecystitis or biliary obstruction.

Interpretation of Results

Normal Findings

• The tracer moves promptly from the liver into the gallbladder and small intestine.
• The gallbladder contracts well in response to Sincalide, with an Ejection Fraction (GBEF) typically >35–40%.

Abnormal Findings

• Low Ejection Fraction (<35%): Suggestive of Biliary Dyskinesia.
• Non-visualization: If the gallbladder does not fill after 4 hours, it may indicate chronic cholecystitis or cystic duct obstruction.
• Delayed Transit: May indicate partial obstruction or Sphincter of Oddi dysfunction.

Frequently Asked Questions (FAQ)

1. Does the HIDA scan hurt?

The procedure is painless. You may feel a slight pinch during the IV insertion and some mild abdominal cramping during the Sincalide infusion.

2. How long does the entire scan take?

The procedure typically takes between 90 minutes to 3 hours, depending on how quickly your system processes the tracer.

3. Can I eat before the test?

No. Fasting for 4–6 hours is required. Eating beforehand will cause your gallbladder to contract, making it impossible to accurately measure the ejection fraction.

4. What is biliary dyskinesia?

It is a condition where the gallbladder does not squeeze out bile efficiently, even though there are no stones present. It causes pain similar to gallstones.

5. Will I be radioactive after the test?

The radiation dose is very small and decays quickly. You can safely interact with adults, though it is usually recommended to avoid prolonged close contact with infants or pregnant women for 24 hours.

6. What if the gallbladder doesn't show up?

If the gallbladder is not visualized, the radiologist may administer morphine (if not contraindicated) to stimulate gallbladder filling, or conclude that the gallbladder is non-functional.

7. Is Sincalide the same as CCK?

Sincalide is the synthetic form of CCK (Cholecystokinin). It is used because it is standardized and safe for medical administration.

8. What are the common side effects of Sincalide?

Some patients experience nausea, abdominal cramping, dizziness, or a metallic taste in the mouth during the infusion. These symptoms are usually brief.

9. Can I drive after the scan?

Yes, there are no sedative medications used in a standard HIDA scan, so you can resume normal activities immediately.

10. Why is this better than an ultrasound?

An ultrasound is excellent at finding stones, but it cannot tell you how well the gallbladder functions. The HIDA scan with CCK is a functional test.

Conclusion

The HIDA scan with CCK stimulation remains the "gold standard" for evaluating gallbladder motility. By combining nuclear medicine imaging with a pharmacological challenge, clinicians can pinpoint the exact cause of biliary-type pain, allowing for targeted surgical or medical interventions. If you are experiencing persistent RUQ pain despite clear ultrasound results, consult with your gastroenterologist or surgeon about the potential benefits of this diagnostic study.